Join Now

Author Archives: admin

New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment

By admin | Published November 25, 2020

Novel Interventional Oncology Embolization Device Successfully Used in Trans-Radial Access Procedures for Tumor Devascularization November 24, 2020 – Fluidx Medical Technology reported successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. “We are impressed with the GPX embolic,” said Andrew Holden, M.D., MBChB, FRANZCR, EBIR, ONZM, […]

Posted in Policy News | Leave a comment

COVID-19 Vaccination Briefing From the State of Utah.

By admin | Published November 20, 2020

View the briefing below: COVID-19 Vaccination Update_11-17-2020

Posted in COVID-19 Updates, State News | Leave a comment

University of Utah to Speed Process of Bringing New Therapeutics to Patients

By admin | Published November 20, 2020

University of Utah Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center: Nov 18, 2020 10:00 AM The university’s Huntsman Cancer Institute (HCI), College of Pharmacy, and the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center have partnered to establish the University of Utah Therapeutics Accelerator Hub (U2TAH, or the Accelerator). Photo credit: University […]

Posted in Industry News, Policy News | Leave a comment

U named Innovation and Economic Prosperity University

By admin | Published November 13, 2020

Article Courtesy of @theU The Association of Public and Land-grant Universities (APLU) awarded the University of Utah the Innovation and Economic Prosperity designation, which recognizes universities that promote growth, innovation and economic development in their regions. “This is tremendous recognition of the important role the University of Utah plays as an economic engine for our state,” […]

Posted in Policy News | Leave a comment

Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels

By admin | Published November 12, 2020

Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas. Dr. Richard Saxon, FSIR and member of the SDI Medical Group, while working at  Tri City Medical Center Medical Center,  Oceanside, California, USA performed the first procedures using […]

Posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

BioUtah Launches BioHive Initiative to Promote Utah’s Life Sciences Industry

By admin | Published November 9, 2020

Article courtesy of BusinessWire Local leaders to create ecosystem for innovation, job creation, and growth SALT LAKE CITY–(BUSINESS WIRE)–Since 2012, Utah’s life sciences community has grown faster than any other in the country. Through collective efforts of the more than 1,100 life sciences-related companies (and growing), it intends to continue that trend and join the […]

Posted in Life Sciences Industry News | Leave a comment

Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance

By admin | Published November 6, 2020

Logan, UT, October 28, 2020 – Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody test. A positive IgG antibody result identifies patients who have been exposed to the SARS-CoV-2 virus and, as part of their recovery, demonstrated an adaptive […]

Posted in Industry News | Leave a comment

Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

By admin | Published October 9, 2020

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY, October 5, 2020–– Xenocor, Inc. offering the world’s first disposable articulating laparoscope, has received a group purchasing agreement with Premier Inc. for their single use Xenoscope™, in the surgical disposable scope category. The Xenocor disposable laparoscopic system […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor

By admin | Published October 9, 2020

For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October 5, 2020 – Mountain Pacific Venture Fund (MPVF) announced an investment in Xenocor, a Salt Lake City, Utah-based medical device company that has developed the Xenoscope™, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

2020 Bench to Bedside Participants Announced

By admin | Published September 18, 2020

Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]

Posted in Industry News | Leave a comment

Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

By admin | Published September 11, 2020

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]

Posted in BioUtah News, Life Sciences Industry News | Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

By admin | Published September 11, 2020

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members